Browse the evidence

Financial incentives, environmental change strategies, and their combination were not significantly more effective than usual care.

Practitioners should consider that these interventions may not provide significant advantages over standard care.

There is a need to develop new cost-effective strategies for OSA management.

Practitioners should consider implementing innovative and cost-effective strategies for managing OSA.

Less than half of obese patients were considering weight loss in the coming month.

Practitioners should address motivation and readiness to change in obese CHD patients.

The safety profile of tirzepatide is consistent across all phase 3 trials.

Practitioners can expect a consistent safety profile when prescribing tirzepatide.

Effect sizes of GLP-1 receptor agonists in schizophrenia are mostly smaller than in the general population.

While GLP-1 receptor agonists can aid in weight loss, practitioners should manage expectations regarding the magnitude of effect in this population.

Future trials of GLP-1 receptor agonists could focus on dual or triple agonist agents.

Exploring dual or triple agonist therapies may enhance treatment options for weight management in schizophrenia.

Subjects trained in record keeping did not differ from untrained subjects in terms of energy intake reporting accuracy.

Training in dietary record keeping may not improve the accuracy of self-reported intake.

The study could not establish statistical significance regarding the likelihood of delayed gastric emptying in patients on GLP-1R agonists.

Further research is needed to clarify the relationship between GLP-1R agonists and gastric emptying.

Recommendations for incorporating genetics and genomics into clinical decision-making for behavioral weight loss are outlined.

Practitioners can consider these recommendations to enhance behavioral weight loss interventions.

Lifestyle interventions and older antiobesity pharmacotherapies have been associated with less than 12% body weight reduction and no clear benefit to reduce MACE risk.

Practitioners should be aware that traditional weight loss methods may not significantly reduce cardiovascular risks.

Barriers to providing advice on specific dietary patterns for T2DM include safety and compliance challenges.

Dietitians should be aware of and address safety and compliance issues when advising patients.

Genetic predisposition to higher BMI does not predict weight regain after weight loss.

Genetic factors related to BMI may not be useful for predicting weight regain, focusing instead on abdominal obesity genetics.

Genetic effects on abdominal obesity may be more pronounced than those on general obesity during weight regain.

Understanding the differential impact of genetics on abdominal versus general obesity can inform targeted interventions.

Companies can profit from CCT programs by selling enrollment as self-commitment devices.

Businesses can leverage CCT programs as a market opportunity while promoting healthier behaviors.

There is a need for sport event organizers to question and challenge claims of health promotion.

Sport organizations should critically evaluate their health promotion strategies and claims.

Researchers have failed to reach a consensus on the potential benefits of fad diets for weight loss.

Practitioners should be cautious in recommending fad diets for weight loss due to lack of consensus on their efficacy.

Fad diets vary widely in their approaches, including very low carbohydrate and very low fat options.

Practitioners should be aware of the diverse types of fad diets when discussing dietary options with patients.

An inverse relationship was found between the sitting height to total height ratio and the SDL:CDL strength ratio.

Individuals with longer torsos may benefit more from the SDL.

There is an urgent need to develop effective therapies for diabetes to reduce the risks of serious complications.

Healthcare systems should prioritize the development of new diabetes therapies.

The most common components of metabolic syndrome in the cohort were abdominal obesity and elevated blood pressure.

Understanding common MetS components can guide targeted interventions.

For 13 dietary risk factors, the best pooled unbiased effect size on disease was identified.

Practitioners can use these effect sizes to inform dietary recommendations.

Low energy availability did not enhance performance when expressed relative to body mass.

Performance assessments should consider body mass to accurately evaluate the effects of energy availability.

In the intervention group, there was statistically significantly higher Part B spending compared to the control group (difference, $513; P = .02).

Practitioners should be aware that while overall spending did not decrease, specific areas like Part B spending increased.

No evidence of a relationship was found between RIR accuracy and biological sex, years of RT experience, or relative bench press strength.

RIR accuracy can be considered independent of these demographic and experiential factors.